A new compartmental method for the analysis of liver FDG kinetics in small animal models

BackgroundCompartmental analysis is a standard method to quantify metabolic processes using fluorodeoxyglucose-positron emission tomography (FDG-PET). For liver studies, this analysis is complex due to the hepatocyte capability to dephosphorylate and release glucose and FDG into the blood. Moreover, a tracer is supplied to the liver by both the hepatic artery and the portal vein, which is not visible in PET images. This study developed an innovative computational approach accounting for the reversible nature of FDG in the liver and directly computing the portal vein tracer concentration by means of gut radioactivity measurements.MethodsTwenty-one mice were subdivided into three groups: the control group ‘CTR’ (n = 7) received no treatment, the short-term starvation group ‘STS’ (n = 7) was submitted to food deprivation with free access to water within 48 h before imaging, and the metformin group ‘MTF’ (n = 7) was treated with metformin (750 mg/Kg per day) for 1 month. All mice underwent a dynamic micro-PET study for 50 min after an 18F-FDG injection. The compartmental analysis considered two FDG pools (phosphorylated and free) in both the gut and liver. A tracer was carried into the liver by the hepatic artery and the portal vein, and tracer delivery from the gut was considered as the sole input for portal vein tracer concentration. Accordingly, both the liver and gut were characterized by two compartments and two exchange coefficients. Each one of the two two-compartment models was mathematically described by a system of differential equations, and data optimization was performed by applying a Newton algorithm to the inverse problems associated to these differential systems.ResultsAll rate constants were stable in each group. The tracer coefficient from the free to the metabolized compartment in the liver was increased by STS, while it was unaltered by MTF. By contrast, the tracer coefficient from the metabolized to the free compartment was reduced by MTF and increased by STS.ConclusionsData demonstrated that our method was able to analyze FDG kinetics under pharmacological or pathophysiological stimulation, quantifying the fraction of the tracer trapped in the liver or dephosphorylated and released into the bloodstream.

[1]  Susanne Keiding,et al.  Bringing Physiology into PET of the Liver , 2012, The Journal of Nuclear Medicine.

[2]  M E Phelps,et al.  Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  J. Borwein,et al.  Direct reconstruction of functional parameters for dynamic SPECT , 1995 .

[4]  Guobao Wang,et al.  Direct Estimation of Kinetic Parametric Images for Dynamic PET , 2013, Theranostics.

[5]  F. Mortensen,et al.  Hepatic Blood Perfusion Measured by 3-Minute Dynamic 18F-FDG PET in Pigs , 2011, The Journal of Nuclear Medicine.

[6]  Juhani Knuuti,et al.  Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET Study. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  A. Alstrup,et al.  Tracer input for kinetic modelling of liver physiology determined without sampling portal venous blood in pigs , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[9]  Sung-Cheng Huang,et al.  Estimation of the 18F-FDG Input Function in Mice by Use of Dynamic Small-Animal PET and Minimal Blood Sample Data , 2007, Journal of Nuclear Medicine.

[10]  M. Jensen,et al.  Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. , 2000, Diabetes.

[11]  L. Bass,et al.  Liver kinetics of glucose analogs measured in pigs by PET: importance of dual-input blood sampling. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Piana,et al.  A novel description of FDG excretion in the renal system: application to metformin-treated models. , 2014, Physics in medicine and biology.

[13]  P. Iozzo,et al.  Quantification of liver perfusion with [(15)O]H(2)O-PET and its relationship with glucose metabolism and substrate levels. , 2008, Journal of hepatology.

[14]  Sara Garbarino,et al.  Estimate of FDG Excretion by means of Compartmental Analysis and Ant Colony Optimization of Nuclear Medicine Data , 2013, Comput. Math. Methods Medicine.

[15]  G. Mithieux,et al.  Glucose-6-Phosphatase mRNA and Activity Are Increased to the Same Extent in Kidney and Liver of Diabetic Rats , 1996, Diabetes.

[16]  A. Tikhonov,et al.  Numerical Methods for the Solution of Ill-Posed Problems , 1995 .

[17]  P. Iozzo,et al.  Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes. , 2003, Diabetes care.

[18]  C. Campi,et al.  Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer , 2013, Cell cycle.

[19]  L. Bass,et al.  Determination of regional flow by use of intravascular PET tracers: microvascular theory and experimental validation for pig livers. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Sudheer D. Rani,et al.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input. , 2013, Nuclear medicine and biology.

[21]  M. Cilli,et al.  Metformin Temporal and Localized Effects on Gut Glucose Metabolism Assessed Using 18F-FDG PET in Mice , 2013, The Journal of Nuclear Medicine.

[22]  P. Iozzo,et al.  Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. , 2003, The Journal of clinical endocrinology and metabolism.

[23]  J. Knuuti,et al.  Non-invasive estimation of hepatic glucose uptake from [18F]FDG PET images using tissue-derived input functions , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  D K Smith,et al.  Numerical Optimization , 2001, J. Oper. Res. Soc..

[25]  G. Mithieux,et al.  Liver glucose-6 phosphatase activity is inhibited by refeeding in rats. , 1995, The Journal of nutrition.

[26]  Mathilde Jalving,et al.  Metformin: taking away the candy for cancer? , 2010, European journal of cancer.

[27]  L. Bass,et al.  Impulse-response function of splanchnic circulation with model-independent constraints: theory and experimental validation. , 2003, American journal of physiology. Gastrointestinal and liver physiology.